Sanofi Pasteur, Swiftwater, PA, USA.
Sanofi Pasteur, Toronto, ON Canada.
Vaccine. 2021 Mar 15;39 Suppl 1:A1-A5. doi: 10.1016/j.vaccine.2020.09.005. Epub 2021 Feb 3.
Seasonal influenza has a significant impact on global public health each year, especially in older adults 65 years of age and above. This paper presents the evolution of high-dose influenza vaccine and the quantity as well as quality of evidence on this vaccine. Its introduces other peer-reviewed manuscripts included in this supplement covering the benefits high-dose influenza vaccine over ten consecutive influenza seasons. The development of the high-dose influenza vaccine represents an important step in the evolution of influenza vaccines, offering an advancement in prevention of influenza and a step in encouraging healthy aging in older adults. A video summary of the article can be accessed via the Supplementary data link at the end of this article.
季节性流感每年都会对全球公共卫生产生重大影响，尤其是在 65 岁及以上的老年人中。本文介绍了高剂量流感疫苗的演变以及关于该疫苗的证据数量和质量。本文还介绍了本增刊中其他经过同行评审的论文，这些论文涵盖了高剂量流感疫苗在连续十个流感季节中的益处。高剂量流感疫苗的开发代表了流感疫苗演变的重要一步，为预防流感提供了新的方法，并为鼓励老年人健康老龄化迈出了一步。本文的视频摘要可以通过文末的补充数据链接访问。
